| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |












From the Interdisciplinary Center for Clinical Research,* and the Departments of Nephrology and Hypertension,
Pathology,
and Urology,
Friedrich-Alexander University Erlangen-Nuremberg, Nuremberg; and the Department of Radiation Therapy and Oncology,¶ Johann-Wolfgang-Goethe University Frankfurt, Frankfurt, Germany
The inhibitor of apoptosis protein survivin is of critical importance for regulation of cellular division and survival. Published data point to a restricted function of survivin in embryonic development and cancer; thus survivin has been broadly proposed as an ideal molecular target for specific anti-cancer therapy. In contrast to this paradigm, we report here broad expression of survivin in adult differentiated tissues, as demonstrated at the mRNA and protein levels. Focusing on the kidney, survivin is strongly expressed in proximal tubuli, particularly at the apical membrane, which can be verified in rat, mouse, and human kidneys. In the latter, survivin expression seems to be even stronger in proximal tubuli than in adjacent cancerous tissue. Primary and immortalized human renal tubular cells also showed high levels of survivin protein expression, and RNA interference resulted in a partial G2/M arrest of the cell cycle and increased rate of apoptosis. In conclusion, survivin may be of importance for renal pathophysiology and pathology. The predominant apical expression of survivin may indicate a further, yet unknown, function. Interventional strategies to inhibit survivins function in malignancy need to be carefully (re)evaluated for renal side effects, as well as for other possible organ dysfunctions.
This article has been cited by other articles:
![]() |
K. X. Knaup, K. Jozefowski, R. Schmidt, W. M. Bernhardt, A. Weidemann, J. S. Juergensen, C. Warnecke, K.-U. Eckardt, and M. S. Wiesener Mutual Regulation of Hypoxia-Inducible Factor and Mammalian Target of Rapamycin as a Function of Oxygen Availability Mol. Cancer Res., January 1, 2009; 7(1): 88 - 98. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. G.E. de Vries and S. de Jong Exploiting the Apoptotic Route for Cancer Treatment: A Single Hit Will Rarely Result in a Home Run J. Clin. Oncol., November 10, 2008; 26(32): 5151 - 5153. [Full Text] [PDF] |
||||
![]() |
A. B. Sanz, B. Santamaria, M. Ruiz-Ortega, J. Egido, and A. Ortiz Mechanisms of Renal Apoptosis in Health and Disease J. Am. Soc. Nephrol., September 1, 2008; 19(9): 1634 - 1642. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |